Dopropidil is a novel antianginal calcium modulator with intracellular calcium antagonist activity and anti-ischemic effects in animal models; it reduces ischemia-induced electrical (ST-segment elevation), biochemical (lactate production and potassium release), and mechanical (loss of myocardial segment contractility) disturbances in anesthetized dogs; it significantly attenuates isoproterenol-induced tachycardia following intraduodenal administration, indicating rapid absorption and prolonged duration of action; it also lowers resting heart rate in conscious dogs.